GNPX vs GOVX

Genprex, Inc. vs GeoVax Labs, Inc. — Valuation Comparison 2026

GNPX

Pharmaceutical Preparations
Genprex, Inc.
Quality
3.9
out of 10
Value Trap
24
SAFE
Price
$0.78
Last close
Models
7/13
Active
VS

GOVX

Pharmaceutical Preparations
GeoVax Labs, Inc.
Quality
5.1
out of 10
Value Trap
24
SAFE
Price
$2.06
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType GNPX Fair ValueGNPX Upside GOVX Fair ValueGOVX Upside
Bayesian DCF Intrinsic $1.14 +46.6% $0.82 -60.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.93 +276.4% $8.71 +322.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for GNPX vs GOVX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GNPX vs GOVX — Which Stock Is More Undervalued?

GOVX scores higher with a 5.1/10 quality rating vs GNPX's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Genprex, Inc. (GNPX) and GeoVax Labs, Inc. (GOVX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GNPX currently trades at $0.78 with a QOC of 3.9/10, while GOVX trades at $2.06 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).